Cue Biopharma Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
25 Aug 23 | Buy€10,247 | Anish Suri | Individual | 4,000 | €2.56 | |
14 Aug 23 | Buy€7,861 | Daniel Passeri | Individual | 3,000 | €2.62 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Private Companies | 4,895 | 0.0101% |
Individual Insiders | 505,406 | 1.04% |
Hedge Funds | 2,755,028 | 5.66% |
Institutions | 14,045,948 | 28.9% |
General Public | 31,332,039 | 64.4% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 12.7%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
2,755,028 | €3.7m | 57% | 0.88% | |||
2,402,455 | €3.2m | 0% | 0.07% | |||
2,247,978 | €3.0m | -3.88% | no data | |||
2,132,905 | €2.8m | 0.38% | no data | |||
940,000 | €1.3m | 0% | no data | |||
813,285 | €1.1m | 6.67% | no data | |||
683,695 | €909.5k | -2.08% | no data | |||
478,500 | €636.5k | 0% | 0.04% | |||
457,985 | €609.2k | -19.2% | no data | |||
381,367 | €507.3k | 16% | no data | |||
342,242 | €455.3k | -4.86% | 0.17% | |||
275,645 | €366.7k | -12.2% | no data | |||
266,227 | €354.1k | 41.1% | no data | |||
257,225 | €342.2k | 0% | 0.05% | |||
193,975 | €258.0k | 31.8% | no data | |||
191,536 | €254.8k | 0% | no data | |||
173,867 | €231.3k | 0% | no data | |||
147,209 | €195.8k | 47.8% | no data | |||
135,638 | €180.4k | 0% | no data | |||
134,578 | €179.0k | 0% | no data | |||
120,000 | €159.6k | -11.1% | 0.01% | |||
108,875 | €144.8k | -55.5% | 0.01% | |||
105,691 | €140.6k | 0% | no data | |||
100,000 | €133.0k | -10.7% | 0.01% | |||
99,261 | €132.0k | 25.4% | no data |